Helfrich M H, Livingston E, Franklin I M, Soutar R L
Department of Medicine and Therapeutics, University of Aberdeen, Foresterhill, UK.
Blood Rev. 1997 Mar;11(1):28-38. doi: 10.1016/s0268-960x(97)90004-7.
Malignant plasma cells in multiple myeloma are predominantly confined to the bone marrow, where they stimulate cytokine production by stromal cells and bone cells leading to osteoclast activation and formation of the characteristic lytic lesions in the skeleton. Adhesion molecules are critically involved in the cellular interactions between myeloma cells and stromal elements and may represent novel therapeutic targets to reduce osteolytic bone disease in multiple myeloma. Here, we review the literature on the adhesion molecule repertoire expressed by malignant plasma cells and discuss the evidence that adhesive interactions between myeloma cells and stromal cells stimulate production of bone-resorbing cytokines.
多发性骨髓瘤中的恶性浆细胞主要局限于骨髓,在骨髓中它们刺激基质细胞和骨细胞产生细胞因子,导致破骨细胞活化并在骨骼中形成特征性溶骨性病变。黏附分子在骨髓瘤细胞与基质成分之间的细胞相互作用中起关键作用,可能是减少多发性骨髓瘤溶骨性骨病的新型治疗靶点。在此,我们综述了关于恶性浆细胞表达的黏附分子谱的文献,并讨论了骨髓瘤细胞与基质细胞之间的黏附相互作用刺激骨吸收细胞因子产生的证据。